Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Hepatitis C Infection, Thrombocytopenia

In brief

RATIONALE: Romiplostim may cause the body to make platelets. PURPOSE: This randomized phase II trial is studying how well romiplostim works in treating hepatitis C-infected patients with thrombocytopenia.

Key facts

Study ID

NCT01153919

Run by

University of Southern California

People needed

27

Starts

2010-06-30

Expected to finish

2018-07-14

Last updated by the study team

2017-04-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.